A Review of Methods for Removal of Ceftriaxone from Wastewater

Development of a new synchronous fluorescence spectrometry combined with Al3+ sensitized for simultaneous and rapid determination of trace flumequine, ciprofloxacin and doxycycline hydrochloride residues in wastewater

Antibiotics are a new type of environmental pollutants. Due to its wide application in many fields, antibiotic residues are ubiquitous in the wastewater environments. Given their potential threat on water ecosystem functioning and public health, the detection of antibiotic residues in wastewater environments has become very necessary. Based on the complexation of Al3+ with flumequine (FLU), ciprofloxacin (CIP) and doxycycline hydrochloride (DOX), their molecular conjugated area were increased and fluorescence intensity were enhanced, combined with synchronous fluorescence spectrometry (SFS) had good selectivity and high sensitivity, a novel method of Al3+ sensitized synchronous fluorescence spectrometry for the determination of FLU, CIP and DOX residues in wastewater was established. When the wavelength difference (Δλ) was selected 115.0 nm, synchronous fluorescence spectra of the three antibiotics could be well separated and the interference of wastewater matrix were eliminated primely. The new SFS made good use of spectral separation instead of conventional chemical separation, and the actual wastewater sample could be directly determined after simple filtration. The experiment results showed that the concentrations of FLU, CIP and DOX in the range of 0.5000-800.0 ng·mL-1, 0.5000-640.0 ng·mL-1 and 10.00-3500 ng·mL-1 had a good linear relationship with fluorescence intensity. The detection limits of three antibiotics were 0.02054 ng·mL-1, 0.03956 ng·mL-1 and 0.8524 ng·mL-1, respectively. Recovery rates of three antibiotics in wastewater samples were 90.72%-98.23%, 88.68%-95.08% and 85.94%-96.70%. The new SFS established in this experiment had the advantages of simple, rapid, sensitive, accurate and good selectivity. Simultaneous and rapid detection of FLU, CIP and DOX residues in wastewater was successfully realized. It had good application prospects in real-time water quality monitoring.

Analysis of pharmacokinetic profile and ecotoxicological character of cefepime and its photodegradation products

An important problem is the impact of photodegradation on product toxicity in biological tests, which may be complex and context-dependent. Previous studies have described the pharmacology of cefepime, but the toxicological effects of its photodegradation products remain largely unknown. Therefore, photodegradation studies were undertaken in conditions similar to those occurring in biological systems insilico, in vitro, in vivo and ecotoxicological experiments. The structures of four cefepime photodegradation products were determined by UPLC-MS/MS method. The calculated in silico ADMET profile indicates that carcinogenic potential is expected for compounds CP-1, cefepime, CP-2 and CP-3. The Cell Line Cytomotovity Predictor 2.0 tool was used to predict the cytotoxic effects of cefepime and related compounds in non-transformed and cancer cell lines. The results indicate that possible actions include: non-small cell lung cancer, breast adenocarcinoma, prostate cancer and papillary renal cell carcinoma. OPERA models were used to predict absorption, distribution, metabolism and excretion (ADME) endpoints, and potential bioactivity of CP-2, cefepime and CP-4. The results obtained in silico show that after 96h of exposure, cefepime, CP-1, CP-2, and CP-3 are moderately toxic in the zebrafish model, while CP-4 is highly toxic. On the contrary, cefepime is more toxic to T. platyurus (highly toxic) compared to the zebrafish model, similar to products CP-4, CP-3 and CP-2. In vitro cytotoxicity studies were performed by MTT assay and in vivo acute embryo toxicity studies using Danio rerio embryos and larvae. In vitro showed an increase in the cytotoxicity of products with the longest exposure period i.e. for 8 h. Additionally, at a concentration of 200 μg/mL, statistically significant changes in metabolic activity were observed depending on the irradiation time. In vivo studies conducted with Zebrafish showed that both cefepime and its photodegradation products have only low toxicity. Assessment of potential ecotoxicity included Microbiotests on invertebrates (Thamnotoxkit F and Daphtoxkit F), and luminescence inhibition tests (LumiMara). The observed toxicity of the tested solutions towards both Thamnocephalus platyurus and Daphnia magna indicates that the parent substance (unexposed) has lower toxicity, which increases during irradiation. The acute toxicity (Lumi Mara) of nonirradiated cefepime solution is low for all tested strains (<10%), but mixtures of cefepime and its photoproducts showed growth inhibition against all tested strains (except #6, Photobacterium phoreum). Generally, it can be concluded that after UV-Vis irradiation, the mixture of cefepime phototransformation products shows a significant increase in toxicity.

Next-generation hybrid technologies for the treatment of pharmaceutical industry effluents

Water and industries are intangible units of the globe that are always set to meet the population's demand. The global population depends on one-third of freshwater increasing the demand. The increase in population along with urbanization has polluted the fresh water resources. The pharmaceutical industry is marked as an emerging contaminant of water pollution. The most common type of pharmaceutical drugs that are detected in the environment includes antibiotics, analgesics, NSAIDs, and pain-relieving drugs. These drugs alter the food chain of the organisms causing chaos mainly in the marine ecosystem. Pharmaceutical drugs are found only in shallow amounts (ng/mg) they have a huge impact on the living system. The consumption of water contaminated with pharmaceutical ingredients can disrupt reproduction, hormonal imbalance, cancer, and respiratory problems. Various methods are used to remove these chemicals from the environment. In this review, we mainly focused on the emerging hybrid technologies and their significance in the effective treatment of pharmaceutical wastewater. This review paper primarily elaborates on the merits and demerits of existing conventional technologies helpful in developing integrated technologies for the modern era of pharmaceutical effluent treatment. This review paper further in detail discusses the various strategies of eco-friendly bioremediation techniques namely biostimulation, bioaugmentation, bacterial degradation, mycoremediation, phytoremediation, and others for the ultimate removal of pharmaceutical contaminants in wastewater. The review makes clear that targeted and hybrid solutions are what the world will require in the future to get rid of these pharmacological prints.

Robust PbO2 modified by co-deposition of ZrO2 nanoparticles for efficient degradation of ceftriaxone sodium

In recent years, PbO2 electrodes have received widespread attention due to their high oxygen evolution reaction (OER) activity. However, due to the brittle nature of the plating layer, it is easy to cause the active layer to fall off. Pb2+ will leach out with the electrochemical process causing secondary pollution. The starting point of this study is established to improve the stability and adhesion of the electrode coating. Electrochemical oxidation technology has the characteristics of high treatment efficiency, wide range of applications, and non-polluting environment. In this study, conventional PbO2 electrodes were modified by using co-deposition of ZrO2 nanoparticles. In addition, α-PbO2 was added to increase the stability of the electrodes. At a high current density of 1 A/cm2, the accelerated life of the pure PbO2 electrode is 648 h, the accelerated life of the PbO2-ZrO2 electrode is 1.37 times that of the pure PbO2, and the electrode with an added α-PbO2 layer is 1.69 times that of the pure PbO2 electrode. The amount of dissolved Pb2+ was only 29% of that of pure PbO2. The electrochemical performance of the electrode is evaluated by studying the degradation effect of ceftriaxone sodium (CXM). The addition of ZrO2 nanoparticles alters the particle size and deposition content of PbO2, leading to a unique crystal structure distinct from pure PbO2. Compared to conventional PbO2 electrodes, the PbO2-ZrO2 can remove chemical oxygen demand (COD) and pollutants more efficiently, removing for 59% increased by 38.47%. Therefore, PbO2-ZrO2 is of great value in the field of electrochemical degradation of industrial pollutants.

Exploring fluorescence of metal nanoparticles for effective utility in drug sensing: A Promising ''on-off'' fluorescence probe for analysis of cephalosporins is fabricated

A promising fluorescent nano sensor was fabricated exploiting the unique optical and physicochemical properties of silver nanoparticles (AgNPs). AgNPs were prepared following a chemical reduction technique to get a highly water-soluble nano sensor, stable for at least 1 month without the need of organic stabilizers. Full characterization of AgNPs was done using different spectroscopic and microscopic techniques. They exhibit excellent water solubility, physicochemical and optical properties, enabling them to be successfully applied in chemical sensing of drugs. The prepared AgNPs could be conceived as a fluorescent probe for the fluorimetric determination of two commonly administered cephalosporins ceftriaxone (CTX) and cefepime (CFP) based on the quenching behavior of the fluorescence omitting the need for pre-derivatization or chromogenic reagents. The fluorescence intensity of AgNPs at 485 nm after excitation at 242 nm was quantitively quenched upon increasingly adding the studied drugs over the concentration ranges of 1-10 µg/mL and 0.9-9 µg/mL with detection limits of 0.178 µg/mL and 0.145 µg/mL for CTX and CFP, respectively. The quenching mechanisms were investigated and illustrated. The influence of different experimental parameters was studied and optimized. The suggested sensor provides an innovative, sensitive, and eco-friendly approach for the assay of the drugs in their pharmaceutical vials and quality control laboratories with excellent % recoveries of 99.88 ± 1.15, 99.95 ± 1.15 for CTX and CFP, respectively. The method was validated in accordance with ICH Q2 R1 recommendations. The greenness evaluation was performed through both Eco-Scale and GAPI revealing the green criteria of the developed method.

Long-term effects on liver metabolism induced by ceftriaxone sodium pretreatment

Ceftriaxone is an emerging contaminant due to its potential harm, while its effects on liver are still need to be clarified. In this study, we first pretreated the 8-week-old C57BL/6J mice with high dose ceftriaxone sodium (Cef, 400 mg/mL, 0.2 mL per dose) for 8 days to prepare a gut dysbiosis model, then treated with normal feed for a two-month recovery period, and applied non-targeted metabolomics (including lipidomics) to investigate the variations of fecal and liver metabolome, and coupled with targeted determination of fecal short-chain fatty acids (SCFAs) and bile acids (BAs). Lastly, the correlations and mediation analysis between the liver metabolism and gut metabolism/microbes were carried, and the potential mechanisms of the mal-effects on gut-liver axis induced by Cef pretreatment were accordingly discussed. Compared to the control group, Cef pretreatment reduced the rate of weight gain and hepatosomatic index, induced bile duct epithelial cells proliferated around the central vein and appearance of binucleated hepatocytes, decreased the ratio of total branching chains amino acids (BCAAs) to total aromatic amino acids (AAAs) in liver metabolome. In fecal metabolome, the total fecal SCFAs and BAs did not change significantly while butyric acid decreased and the primary BAs increased after Cef pretreatment. Correlation and mediation analysis revealed one potential mechanism that Cef may first change the intestinal microbiota (such as destroying its normal structure, reducing its abundance and the stability of the microbial network or certain microbe abundance like Alistipes), and then change the intestinal metabolism (such as acetate, caproate, propionate), leading to liver metabolic disorder (such as spermidine, inosine, cinnamaldehyde). This study proved the possibility of Cef-induced liver damage, displayed the overall metabolic profile of the liver following Cef pretreatment and provided a theoretical framework for further research into the mechanism of Cef-induced liver damage.

Predicted Environmental Risk Assessment of Antimicrobials with Increased Consumption in Portugal during the COVID-19 Pandemic; The Groundwork for the Forthcoming Water Quality Survey

The environmental release of antimicrobial pharmaceuticals is an imminent threat due to ecological impacts and microbial resistance phenomena. The recent COVID-19 outbreak will likely lead to greater loads of antimicrobials in the environment. Thus, identifying the most used antimicrobials likely to pose environmental risks would be valuable. For that, the ambulatory and hospital consumption patterns of antimicrobials in Portugal during the COVID-19 pandemic (2020–2021) were compared with those of 2019. A predicted risk assessment screening approach based on exposure and hazard in the surface water was conducted, combining consumption, excretion rates, and ecotoxicological/microbiological endpoints in five different regions of Portugal. Among the 22 selected substances, only rifaximin and atovaquone demonstrated predicted potential ecotoxicological risks for aquatic organisms. Flucloxacillin, piperacillin, tazobactam, meropenem, ceftriaxone, fosfomycin, and metronidazole showed the most significant potential for antibiotic resistance in all analysed regions. Regarding the current screening approach and the lack of environmental data, it is advisable to consider rifaximin and atovaquone in subsequent water quality surveys. These results might support the forthcoming monitorisation of surface water quality in a post-pandemic survey.

Removal of ceftriaxone sodium antibiotic from pharmaceutical wastewater using an activated carbon based TiO2 composite: Adsorption and photocatalytic degradation evaluation

The water pollution becomes a serious concern for the sustainability of ecosystems due to the existence of pharmaceutical products (ceftriaxone (CEF) antibiotic). Even in low concentration of CEF has lethal effects on ecosystem and human health. To remove CEF, TiO₂ is considered as an effective and efficient nanoparticles, however its performance is reduced due to wider energy gap and rapid recombination of charge carriers. In this study, activated carbon based TiO₂ (ACT-X) heterogeneous nanocomposites were synthesized to improve the intrinsic properties of TiO₂ and their adsorption-photocatalytic performance for the removal of CEF. The characterization results revealed that ACT-X composites have slower recombination of charge carriers, lower energy band gap (3.05 eV), and better light absorption under visible region of light. From ACT-X composites, the ACT-4 photocatalyst has achieved highest photocatalytic degradation (99.6%) and COD removal up (99.2%). The results of radical scavengers showed that photocatalytic degradation of CEF is mainly occurred due to superoxide and hydroxyl radicals. Meanwhile, the reusability of ACT-4 up to five cycles shows more than 80% photocatalytic degradation, which make the process more economical. The highest experimental adsorption capacity is achieved up to 844.8 mg g^-1 using ACT-4. The favorable and multilayer heterogeneous adsorption is carried out according to the well-fitted data with pseudo-second-order and Freundlich models, respectively. These results indicate that the carbon-based TiO₂ composites can be used as a green, stable, efficient, effective, reusable, renewable, and sustainable photocatalyst to eliminate the pharmaceutical pollutants (antibiotics) via adsorption and photocatalytic degradation processes.